Breaks Categories: News

WednesdayJul 31, 2019 10:35 am

NetworkNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) to Equip Australian Government Vehicles as Part of a Cellular Vehicle-to-Everything Pilot Program

Global developer and provider of cellular communications systems Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) today announced its receipt of a purchase order from a distributor to equip various government vehicles in Australia with the CP250 in-vehicle cellular device. Per the update, the CP250 order is part of a Cellular Vehicle-to-Everything (“C-V2X”) pilot program. “C-V2X is a worldwide, game-changing technology to improve the safety of travelers and pedestrians while reducing congestion and carbon emissions,” Siyata Mobile CEO Marc Seelenfreund stated in the news release. “Analytics from CV2X are immensely valuable in the building of smart cities and our CP250 provides…

Continue Reading

WednesdayJul 31, 2019 10:00 am

NetworkNewsBreaks – IONIC Brands Corp.’s (CSE: IONC) (OTC: IONKF) (FRA: IB3) Zoots Premium Cannabis Infused Edibles to Launch in PharmaCann’s Illinois Dispensaries

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) today announced that national vertically integrated cannabis operator PharmaCann LLC will exclusively launch its Zoots Cannabis Infused Edibles in Illinois dispensaries. According to the update, the edibles will be available this month. Verilife dispensaries, which are owned and operated by PharmaCann, will offer drops, chews and energy shots from the Zoots product line. “Zoots is an ideal fit for Illinois medical cannabis patients seeking relief through a premium edible product that delivers consistent and reliable results,” PharmaCann Chief Operating Officer Brett Novey said in the news release. “We are excited to offer…

Continue Reading

WednesdayJul 31, 2019 9:25 am

NetworkNewsBreaks – City View Green Holdings Inc. (CSE: CVGR) Closes Sale, Leaseback of Brantford Facility

City View Green Holdings (CSE: CVGR) on Tuesday announced the successful completion of the transfer of its option to purchase 49 Easton Road in Brantford to an arms-length financier who has now acquired the property. In exchange, CVGR and the new landlord have entered a five-year lease with a renewable term of five years. The landlord has agreed to finance all the necessary buildout and capital enhancements that are required for CVGR to obtain its Health Canada Licenses needed to turn the facility into a fully operational cannabis grow and extraction facility. Per the terms of the lease agreement, CVGR…

Continue Reading

TuesdayJul 30, 2019 10:56 am

NetworkNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Commences CO2 Extraction Operations at Napanee Facility

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this morning announced that its wholly-owned subsidiary, ABcann Medicinals Inc., has received Health Canada approval to commence extraction operations using its on-site super-critical CO2 extraction system. According to the update, upon its Napanee facility’s receipt of EU-GMP certification and subject to receipt of all necessary import and export permits, the company is expected to be able to ship extracted cannabis products to Europe and other countries for scientific and medical purposes, in addition to selling domestically. "We are extremely excited to commence CO2 extraction operations at our Napanee facility," Vice-President, Napanee Operations Gary…

Continue Reading

TuesdayJul 30, 2019 10:39 am

NetworkNewsBreaks – Forty Seven, Inc. (NASDAQ: FTSV) Secures $86.3 Million in Underwritten Public Offering

Forty Seven (NASDAQ: FTSV), a clinical stage immuno-oncology company, has closed an underwritten public offering of 10,781,250 shares of its common stock, which includes 1,406,250 additional shares per the full exercise of the over-allotment option granted to the underwriters. According to the update, the offering resulted in gross proceeds of approximately $86.3 million to Forty Seven, Inc., with each of the shares sold at the public offering price of $8.00. ROTH Capital Partners acted as co-manager for the offering. To view the full press release, visit http://nnw.fm/yMP0J About Forty Seven, Inc. Forty Seven, Inc. is a clinical-stage immuno-oncology company that…

Continue Reading

TuesdayJul 30, 2019 10:12 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Summarizes DehydraTECH(TM) Technology Licensees

Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today reported on its existing technology licensees that have entered definitive contracts to use its revolutionary DehydraTECH(TM) absorption technology within their existing and emerging brands. “The first half of 2019 delivered a period of unprecedented achievements for Lexaria. We signed more license agreements than ever before in our Company’s history, many of which were larger in scope than anything previous,” Lexaria Chief Executive Officer Chris Bunka said in the news release. “We also launched our brand-new business division Lexaria Nicotine which is disrupting nicotine delivery methods that…

Continue Reading

TuesdayJul 30, 2019 9:56 am

NetworkNewsBreaks – Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Announces Q1 2020 Financial Results

Sproutly Canada (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) on Monday announced its financial results for the first quarter ended May 31, 2019. Among the updates, the company’s cash position was $3.85 million as of May 31, 2019; Toronto Herbal Remedies Inc. has received a Health Canada processing license; and the company entered into a definitive agreement with OCC Holdings Ltd., an affiliate of Moosehead Breweries Ltd, to form a joint venture. "We are off to a strong start in 2020 with the completion of our first quarter, which saw us sign the definitive agreement with Moosehead and make advancements in…

Continue Reading

TuesdayJul 30, 2019 9:41 am

NetworkNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Posts Updated Terms to Spring Oaks Acquisition

Green Growth Brands (CSE: GGB) (OTCQB: GGBXF), a lifestyle-oriented cannabis company, on Monday announced an amendment to the share purchase agreement dated June 3, 2019 with Spring Oaks Greenhouses, Inc. Per the amended agreement, GGBXF will acquire all of the issued and outstanding shares of capital stock of Spring Oaks. According to the amendment, the purchase price of $54,650,000 will be comprised of a previously paid deposit of $1,350,000; a cash payment of $2,000,000 at closing, subject to certain adjustments acknowledged in the agreement; a cash payment of $3,000,000 due on August 31, 2019; the issuance of 7,133,297 common shares…

Continue Reading

MondayJul 29, 2019 12:22 pm

NetworkNewsBreaks – Trxade Group Inc. (TRXD) Reports Record Revenues, Increased Gross Profit and Operating Income in Q2 2019

Trxade Group (OTCQB: TRXD), an integrated pharmaceutical services company, today announced the company’s financial results for its second quarter, ended June 30, 2019, as well as provided a business update and positive outlook for the rest of 2019. Among the highlights, Trxade reported generating record revenues of $1,916,414 for second quarter 2019 compared to $837,688 for the same quarter last year. In addition, gross profit for the company increased to $1,163,276 from $837,688 and operating income increased to $132,705 from $31,446 in the quarter ending June 30, 2019 and 2018, respectively. The company attributes the increase in revenue primarily to…

Continue Reading

MondayJul 29, 2019 10:57 am

NetworkNewsBreaks – Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) Closes $75 Million IPO

Mirum Pharmaceuticals (NASDAQ: MIRM), a clinical-stage therapeutics company developing a novel approach for treating cholestatic liver diseases, has closed an initial public offering of 5,000,000 shares of its common stock. According to the update, the offering resulted in gross proceeds of $75 million for Mirum Pharmaceuticals, with shares sold at the public offering price of $15.00 each. The shares began trading on the Nasdaq Global Market under the symbol “MIRM” on July 18, 2019. ROTH Capital Partners acted as co-manager for the offering. To view the full press release, visit http://nnw.fm/EQFx9 About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a…

Continue Reading